Koninklijke Philips Income Taxes 2010-2025 | PHG
- Koninklijke Philips income taxes for the quarter ending March 31, 2025 were $0.028B, a 276.67% decline year-over-year.
- Koninklijke Philips income taxes for the twelve months ending March 31, 2025 were $0.517B, a 1877.92% increase year-over-year.
- Koninklijke Philips annual income taxes for 2024 were $1.042B, a 1418.93% decline from 2023.
- Koninklijke Philips annual income taxes for 2023 were $-0.079B, a 33.64% decline from 2022.
- Koninklijke Philips annual income taxes for 2022 were $-0.119B, a 2.3% decline from 2021.
Koninklijke Philips Annual Income Taxes (Millions of US $) |
|
---|---|
2024 | $1,042 |
2023 | $-79 |
2022 | $-119 |
2021 | $-122 |
2020 | $324 |
2019 | $377 |
2018 | $228 |
2017 | $394 |
2016 | $362 |
2015 | $265 |
2014 | $35 |
2013 | $619 |
2012 | $396 |
2011 | $394 |
2010 | $676 |
2009 | $139 |
Koninklijke Philips Quarterly Income Taxes (Millions of US $) |
|
---|---|
2025-03-31 | $28 |
2024-09-30 | $71 |
2024-06-30 | $372 |
2023-06-30 | $46 |
2023-03-31 | $-16 |
2022-06-30 | $-11 |
2021-06-30 | $13 |
2020-06-30 | $40 |
2019-06-30 | $83 |
2018-06-30 | $75 |
2017-06-30 | $48 |
2016-12-31 | $218 |
2016-09-30 | $7 |
2016-06-30 | $54 |
2016-03-31 | $83 |
2015-12-31 | $168 |
2015-09-30 | $9 |
2015-06-30 | $53 |
2015-03-31 | $35 |
2014-12-31 | $-23 |
2014-09-30 | $-50 |
2014-06-30 | $55 |
2014-03-31 | $53 |
2013-12-31 | $227 |
2013-09-30 | $143 |
2013-06-30 | $158 |
2013-03-31 | $91 |
2012-12-31 | $76 |
2012-09-30 | $80 |
2012-06-30 | $114 |
2012-03-31 | $126 |
2011-12-31 | $105 |
2011-09-30 | $91 |
2011-06-30 | $66 |
2011-03-31 | $133 |
2010-12-31 | $297 |
2010-09-30 | $99 |
2010-06-30 | $105 |
2010-03-31 | $175 |
2009-12-31 | $169 |
2009-09-30 | $80 |
2009-06-30 | $114 |
2009-03-31 | $-224 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Products Manufacturing | $23.245B | $19.503B |
Koninklijke Philips N.V. is the parent company of the Philips Group. The company realigned its three reporting operations into Diagnosis & Treatment businesses consists of Diagnostic Imaging, Ultrasound, Image-Guided Therapy and Enterprise Diagnostic Informatics businesses. Connected Care business comprises the Monitoring & Analytics, Therapeutic Care, Population Health Management, Sleep & Respiratory Care and Connected Care Informatics businesses. Personal Health business consists of the Oral Healthcare, Mother & Child Care and Personal Care. Other consists of Innovation, Emerging Businesses, IP Royalties, Central costs and Other. Notably, Philips completed the divestiture of Domestic Appliances business. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Abbott Laboratories (ABT) | United States | $233.799B | 28.11 |
Boston Scientific (BSX) | United States | $157.605B | 39.46 |
Stryker (SYK) | United States | $150.214B | 31.41 |
EssilorLuxottica (ESLOY) | France | $126.765B | 0.00 |
Medtronic (MDT) | Ireland | $110.324B | 15.64 |
Lonza Group Ag (LZAGY) | Switzerland | $50.804B | 0.00 |
Haleon (HLN) | United Kingdom | $46.676B | 26.62 |
ResMed (RMD) | United States | $37.413B | 28.10 |
GE HealthCare Technologies (GEHC) | United States | $34.057B | 16.17 |
Agilent Technologies (A) | United States | $33.852B | 22.07 |
Terumo (TRUMY) | Japan | $27.835B | 36.15 |
Insulet (PODD) | United States | $22.033B | 86.49 |
Zimmer Biomet Holdings (ZBH) | United States | $18.095B | 11.62 |
Baxter (BAX) | United States | $15.595B | 11.64 |
Smith & Nephew SNATS (SNN) | United Kingdom | $13.236B | 0.00 |
Demant (WILYY) | Denmark | $9.110B | 0.00 |
Sunny Optical Technology (SNPTF) | China | $8.561B | 0.00 |
Bio-Rad Laboratories (BIO) | United States | $6.639B | 23.10 |
Lantheus Holdings (LNTH) | United States | $5.638B | 14.22 |
Prestige Consumer Healthcare (PBH) | United States | $3.998B | 17.86 |
Perrigo (PRGO) | Ireland | $3.649B | 9.25 |
Haemonetics (HAE) | United States | $3.545B | 16.15 |
Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
Envista Holdings (NVST) | United States | $3.334B | 27.70 |
ICU Medical (ICUI) | United States | $3.244B | 23.92 |
QuidelOrtho (QDEL) | United States | $1.952B | 13.43 |
LeMaitre Vascular (LMAT) | United States | $1.866B | 41.70 |
AtriCure (ATRC) | United States | $1.598B | 0.00 |
AdaptHealth (AHCO) | United States | $1.289B | 13.08 |
Acuren (TIC) | United States | $1.271B | 0.00 |
Green Thumb Industries (GTBIF) | United States | $1.111B | 25.00 |
Phibro Animal Health (PAHC) | United States | $1.040B | 13.30 |
Neogen (NEOG) | United States | $1.027B | 13.14 |
BioLife Solutions (BLFS) | United States | $1.021B | 0.00 |
Kestra Medical Technologies (KMTS) | United States | $0.907B | 0.00 |
InMode (INMD) | Israel | $0.897B | 9.04 |
Owens & Minor (OMI) | United States | $0.685B | 5.69 |
CeriBell (CBLL) | United States | $0.683B | 0.00 |
Maravai LifeSciences Holdings (MRVI) | United States | $0.629B | 0.00 |
Evolus (EOLS) | United States | $0.589B | 0.00 |
Curaleaf Holdings (CURLF) | Canada | $0.531B | 0.00 |
Capricor Therapeutics (CAPR) | United States | $0.509B | 0.00 |
Valneva SE (VALN) | France | $0.494B | 0.00 |
Surmodics (SRDX) | United States | $0.412B | 0.00 |
Tilray Brands (TLRY) | Canada | $0.403B | 0.00 |
VAREX IMAGING (VREX) | United States | $0.354B | 13.00 |
Quanterix (QTRX) | United States | $0.332B | 0.00 |
SNDL (SNDL) | Canada | $0.323B | 0.00 |
SEMPERIT AG HLD (SEIGY) | Austria | $0.301B | 0.00 |
Viemed Healthcare (VMD) | United States | $0.274B | 23.07 |
Cerus (CERS) | United States | $0.271B | 0.00 |
ZimVie (ZIMV) | United States | $0.258B | 11.72 |
Sanuwave Health (SNWV) | United States | $0.256B | 0.00 |
Sanara MedTech (SMTI) | United States | $0.253B | 0.00 |
Brainsway (BWAY) | Israel | $0.250B | 66.10 |
Cresco Labs (CRLBF) | United States | $0.246B | 0.00 |
Aurora Cannabis (ACB) | Canada | $0.233B | 69.17 |
Biote (BTMD) | United States | $0.230B | 6.46 |
OraSure Technologies (OSUR) | United States | $0.225B | 0.00 |
Canopy Growth (CGC) | Canada | $0.224B | 0.00 |
TriSalus Life Sciences (TLSI) | United States | $0.201B | 0.00 |
Utah Medical Products (UTMD) | United States | $0.188B | 15.29 |
Omeros (OMER) | United States | $0.188B | 0.00 |
High Tide (HITI) | Canada | $0.184B | 0.00 |
Organigram Global (OGI) | Canada | $0.181B | 0.00 |
Verano Holdings (VRNOF) | United States | $0.177B | 0.00 |
Exagen (XGN) | United States | $0.149B | 0.00 |
Vireo Growth (VREOF) | United States | $0.144B | 0.00 |
FitLife Brands (FTLF) | United States | $0.120B | 14.81 |
Jin Medical (ZJYL) | China | $0.102B | 0.00 |
Fonar (FONR) | United States | $0.092B | 11.90 |
Oramed Pharmaceuticals (ORMP) | United States | $0.088B | 0.00 |
Veru (VERU) | United States | $0.085B | 0.00 |
Apyx Medical (APYX) | United States | $0.082B | 0.00 |
Quipt Home Medical (QIPT) | United States | $0.078B | 0.00 |
Zynex (ZYXI) | United States | $0.077B | 0.00 |
Cytosorbents (CTSO) | United States | $0.077B | 0.00 |
TerrAscend (TSNDF) | Canada | $0.077B | 0.00 |
MacroGenics (MGNX) | United States | $0.075B | 0.00 |
InterCure (INCR) | Israel | $0.068B | 0.00 |
Agape ATP (ATPC) | $0.066B | 0.00 | |
ImmuCell (ICCC) | United States | $0.061B | 0.00 |
Jushi Holdings (JUSHF) | United States | $0.057B | 0.00 |
Nephros (NEPH) | United States | $0.041B | 55.14 |
United-Guardian (UG) | United States | $0.037B | 12.94 |
Modular Medical (MODD) | United States | $0.037B | 0.00 |
Rockwell Medical (RMTI) | United States | $0.027B | 0.00 |
Safety Shot (SHOT) | United States | $0.023B | 0.00 |
Allurion Technologies (ALUR) | United States | $0.018B | 0.00 |
INLIF (INLF) | $0.016B | 0.00 | |
Meihua Medical Technologies (MHUA) | China | $0.014B | 0.00 |
Cellectar Biosciences (CLRB) | United States | $0.014B | 0.00 |
Flora Growth (FLGC) | United States | $0.014B | 0.00 |
Trinity Biotech (TRIB) | Ireland | $0.012B | 0.00 |
Senestech (SNES) | United States | $0.010B | 0.00 |
Innovative Eyewear (LUCY) | United States | $0.006B | 0.00 |
IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
Akanda (AKAN) | Canada | $0.002B | 0.00 |
Sharps Technology (STSS) | United States | $0.000B | 0.00 |
InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |